Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ENASIDENIB Cause Multiple organ dysfunction syndrome? 25 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Multiple organ dysfunction syndrome have been filed in association with ENASIDENIB (Idhifa). This represents 0.7% of all adverse event reports for ENASIDENIB.

25
Reports of Multiple organ dysfunction syndrome with ENASIDENIB
0.7%
of all ENASIDENIB reports
24
Deaths
21
Hospitalizations

How Dangerous Is Multiple organ dysfunction syndrome From ENASIDENIB?

Of the 25 reports, 24 (96.0%) resulted in death, 21 (84.0%) required hospitalization, and 4 (16.0%) were considered life-threatening.

Is Multiple organ dysfunction syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ENASIDENIB. However, 25 reports have been filed with the FAERS database.

What Other Side Effects Does ENASIDENIB Cause?

Death (650) Off label use (213) Fatigue (202) Nausea (197) Acute myeloid leukaemia (163) Hospitalisation (149) Diarrhoea (144) Decreased appetite (122) Platelet count decreased (113) Drug ineffective (108)

What Other Drugs Cause Multiple organ dysfunction syndrome?

TACROLIMUS (1,847) CYCLOPHOSPHAMIDE (1,597) MYCOPHENOLATE MOFETIL (1,566) PREDNISONE (1,525) DEXAMETHASONE (1,355) METHOTREXATE (1,317) METHYLPREDNISOLONE (1,278) RITUXIMAB (1,188) PREDNISOLONE (1,154) CYCLOSPORINE (933)

Which ENASIDENIB Alternatives Have Lower Multiple organ dysfunction syndrome Risk?

ENASIDENIB vs ENBREL ENASIDENIB vs ENCORAFENIB ENASIDENIB vs ENDOXAN ENASIDENIB vs ENDOXAN BAXTER ENASIDENIB vs ENDOXAN INJ

Related Pages

ENASIDENIB Full Profile All Multiple organ dysfunction syndrome Reports All Drugs Causing Multiple organ dysfunction syndrome ENASIDENIB Demographics